Quality Level
agency
USP/NF, meets USP testing specifications
assay
97.0-103.0%
form
crystalline
color
white
mp
83-86 °C (lit.)
application(s)
pharmaceutical (small molecule)
storage temp.
2-8°C
SMILES string
CC(C)CCC[C@@H](C)[C@@]1([H])CC[C@@]([C@]1(C)CCC/2)([H])C2=C\C=C(C[C@@H](O)CC3)/C3=C
InChI
1S/C27H44O/c1-19(2)8-6-9-21(4)25-15-16-26-22(10-7-17-27(25,26)5)12-13-23-18-24(28)14-11-20(23)3/h12-13,19,21,24-26,28H,3,6-11,14-18H2,1-2,4-5H3/b22-12+,23-13-/t21-,24+,25-,26+,27-/m1/s1
InChI key
QYSXJUFSXHHAJI-YRZJJWOYSA-N
Gene Information
human ... VDR(7421)
General description
胆钙化醇(维生素D3)是一种在皮肤中产生的脂溶性类固醇。
Application
胆钙化醇已被用于:
- 诱导小鼠动脉中膜钙化 (arterial medial calcification,AMC)
- 研究其在肥胖和胰岛素抵抗小鼠模型中对血管钙化(VC)相关血管重塑的影响(ob / ob小鼠)
- 研究其对单层培养物中RWPE2-W99细胞锚定依赖性生长的影响
Biochem/physiol Actions
维生素 D 借以发挥作用的受体是配体依赖性转录因子超家族的成员。调控正常细胞和癌细胞的增殖和分化。对乳腺癌、结肠癌和前列腺癌细胞具有抗增殖和抗转移作用。肠和骨骼中的活化维生素 D 受体维持着钙的吸收和平衡。
维生素 D 通过调控正常细胞和癌细胞增殖和分化的受体而发挥作用。
Still not finding the right product?
Explore all of our products under 胆钙化醇
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 2 Dermal - Acute Tox. 2 Inhalation - Acute Tox. 2 Oral - STOT RE 1 Oral
存储类别
6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges
Expansive vascular remodeling and increased vascular calcification response to cholecalciferol in a murine model of obesity and insulin resistance
Carmo LS, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 39(2), 200-211 (2019)
Cholecalciferol (vitamin D 3) inhibits growth and invasion by up-regulating nuclear receptors and 25-hydroxylase (CYP27A1) in human prostate cancer cells
Tokar EJ and Webber MM
Clinical & Experimental Metastasis, 22(3), 275-284 (2005)
Chronic Kidney Disease-Mineral and Bone Disorder
Handbook of Dialysis Therapy, 685-697 (2016)
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| C1357-250MG | 04061833467411 |
| C1357-1G | 04061833467404 |
| C1357-25G | 04061833467428 |

